戻る
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF)価格
SHEZF 株価推移チャート
SHEZF 配当
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
$0.72
53.44%
$0.25
本日現在の状況：Jan 26, 14:26:20 GMT-5
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 配当情報配当履歴 配当チャート
SHEZF 配当
SHEZF 配当成長率（年間比）
Follow-Up Questions
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.の現在の配当金と年間配当金はいくらですか？
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.の配当性向は何ですか？
SHEZFの配当落ち日はいつですか？
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.はどのくらいの頻度で配当金を支払いますか？
主要データ
前終値
$0.4696
始値
$0.7206
当日レンジ
$0.7206 - $0.7206
52週レンジ
$0.4696 - $0.7206
取引高
25
平均取引高
0
1株当たり利益(TTM)
-0.02
配当利回り
--
時価総額
$158.6M
SHENZHEN HEPALINK PHARMACEUTICAとは何ですか？
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 1,926 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the heparin industry chain, contract development and manufacturing organization (CDMO) of biological macromolecules, and the investment, development, and commercialization of innovative drugs. The firm operates four segments. The Pharmaceutical Formulations segment manufactures and sells enoxaparin sodium injection and others. The Active Pharmaceutical Ingredients (APIs) segment manufactures and sells standard heparin APIs, enoxaparin APIs and others. The CDMO segment provides process development services for pharmaceutical intermediates and APIs, including process research, optimization, analytical testing, and formulation research. The Other segment engages in other product businesses, such as pancreatic enzymes and casings. The firm conducts its business in the domestic and overseas markets.